Global Elastography Imaging Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Elastography Imaging Market Analysis

The elastography imaging market has been expanding rapidly due to its increasing application in the diagnosis of liver diseases, musculoskeletal disorders, and other tissue-related conditions. Elastography, a non-invasive imaging technique used to assess tissue stiffness, is gaining significant traction in medical fields such as radiology, cardiology, and obstetrics/gynecology. This growth is fueled by technological advancements such as Shear Wave Elastography (SWE) and Magnetic Resonance Elastography (MRE), which offer improved precision and faster diagnostic results. Companies such as GE Healthcare, Philips, and Siemens Healthineers have been at the forefront of this innovation, driving advancements in portable and on-platform elastography systems. The market's growth is also supported by the rising demand for non-invasive diagnostic methods, which are less costly and carry fewer risks compared to traditional biopsies. In addition, the growing geriatric population, particularly in regions such as North America and Asia-Pacific, and the increasing prevalence of chronic diseases such as liver fibrosis and musculoskeletal disorders, are contributing to the market’s expansion. As healthcare systems adopt these advanced imaging technologies, the elastography imaging market is expected to continue growing at a robust rate.

Elastography Imaging Market Size

The global elastography imaging market size was valued at USD 5.47 billion in 2024 and is projected to reach USD 11.10 billion by 2032, with a CAGR of 9.23% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Elastography Imaging Market Trends

“Rising Demand for Portable Elastography Systems”

Рынок эластографической визуализации переживает стремительный рост, обусловленный достижениями в области диагностических методов и растущим вниманием к неинвазивным методам тестирования. Одной из заметных тенденций является растущий спрос на портативные системы эластографии, которые обеспечивают гибкость в различных условиях здравоохранения, включая амбулаторные клиники и отдаленные районы. Например, разработка компактных ультразвуковых устройств , оснащенных возможностями эластографии, позволяет проводить быструю диагностику заболеваний печени и опорно-двигательного аппарата в режиме реального времени. Эта тенденция очевидна в инновациях таких компаний, как Mindray, которая выпустила ультразвуковую систему Resona I9 Advanced Technologies с эластографией HiFR Sound Touch для повышения точности диагностики и сокращения времени перехода. Кроме того, растущее использование эластографии для оценки жесткости тканей при таких заболеваниях, как фиброз печени , неалкогольная жировая болезнь печени (НАЖБП) и сердечно-сосудистые заболевания, расширяет рынок. Эти технологические достижения и растущая потребность в неинвазивных, экономически эффективных диагностических инструментах стимулируют постоянный рост рынка эластографической визуализации.

Область применения отчета и сегментация рынка эластографической визуализации        

Определение рынка эластографической визуализации

Эластографическая визуализация — это неинвазивный диагностический метод, используемый для измерения жесткости или эластичности тканей, что может указывать на основные заболевания или состояния. Этот метод основан на ультразвуке, магнитно-резонансной томографии (МРТ) или других технологиях визуализации для оценки жесткости тканей, помогая диагностировать различные медицинские проблемы, в частности фиброз печени, опухоли и заболевания опорно-двигательного аппарата. Анализируя скорость, с которой механическая волна распространяется через ткань, эластография предоставляет важную информацию о структуре и целостности ткани без необходимости биопсии.

Динамика рынка эластографической визуализации

Драйверы

• Рост распространенности хронических заболеваний

Растущая распространенность хронических заболеваний является основным фактором, влияющим на рынок эластографической визуализации. Хронические состояния, такие как фиброз печени, цирроз и рак, растут во всем мире, увеличивая спрос на диагностические технологии, такие как эластография, которые могут обеспечить неинвазивную оценку жесткости тканей в реальном времени. По данным Всемирной организации здравоохранения (ВОЗ), заболевания печени, включая цирроз, являются одной из основных причин смертности во всем мире, при этом, по оценкам, 1,3 миллиона смертей ежегодно связаны с циррозом и раком печени. Например, фиброз печени, который часто является результатом гепатита С, является серьезной проблемой, поскольку около 71 миллиона человек во всем мире инфицированы вирусом гепатита С, многие из которых подвержены риску развития прогрессирующего фиброза печени или цирроза. Эластография играет решающую роль в ранней диагностике этих заболеваний и мониторинге их прогрессирования без необходимости инвазивной биопсии печени. Это растущее бремя болезней в сочетании с растущей потребностью в эффективных и экономически выгодных диагностических инструментах вносит значительный вклад в расширение рынка эластографической визуализации.

• Растущий спрос на раннюю диагностику

Растущий спрос на раннюю диагностику является значительным драйвером рынка эластографической визуализации. Раннее выявление таких заболеваний, как фиброз печени, рак печени и рак молочной железы, имеет решающее значение для улучшения результатов лечения пациентов, поскольку позволяет своевременно вмешаться и улучшить контроль этих состояний. Например, Американское онкологическое общество сообщает, что 5-летняя выживаемость при раке печени может достигать 31% при раннем выявлении по сравнению с 3% при диагностике на поздних стадиях. Аналогичным образом, эластография является неинвазивным инструментом, который помогает в раннем выявлении фиброза печени, который, если его не лечить, может прогрессировать до цирроза или рака печени. Возможность выявления этих заболеваний на ранней стадии с помощью эластографии расширяет возможности лечения и снижает общие расходы на здравоохранение. По мере того, как растет осведомленность о преимуществах раннего выявления, поставщики медицинских услуг все чаще используют технологии эластографии как для диагностики, так и для мониторинга, тем самым подпитывая рыночный спрос на системы эластографической визуализации. Этот сдвиг в сторону ранней диагностики особенно важен, поскольку глобальная заболеваемость раком печени и молочной железы продолжает расти, что еще больше стимулирует внедрение технологий эластографии.

Возможности

• Дальнейшие достижения в технологии эластографии

Advancements in elastography technology present a significant market opportunity by enhancing the accuracy, usability, and clinical applications of elastography systems. Recent improvements in software algorithms, such as the development of more precise shear wave elastography techniques, allow for better differentiation between different stages of liver fibrosis, making the technology even more effective in diagnosing liver diseases. Moreover, innovations in elastography hardware, such as portable ultrasound-based devices, have expanded its accessibility in point-of-care settings, enabling faster, more affordable assessments. Integration with other imaging modalities such as MRI further amplifies its diagnostic potential. For Instance, MRI elastography combines the high-resolution capabilities of MRI with elastography, offering a non-invasive, highly accurate method for assessing liver stiffness and detecting tumors in a variety of organs. These technological advancements enhance diagnostic capabilities and drive the growing adoption of elastography across various medical disciplines, including hepatology, oncology, and musculoskeletal imaging. As a result, healthcare providers are increasingly integrating elastography into their practices, creating a significant opportunity for market growth.

• Increasing Awareness and Acceptance of Elastography's Benefits

Increased awareness and acceptance of elastography's benefits is emerging as a key market opportunity, as both healthcare providers and patients become more familiar with its capabilities. Elastography's non-invasive nature and ability to provide real-time, dynamic insights into tissue stiffness make it an attractive alternative to traditional imaging techniques, such as biopsy and CT scans, which are often more invasive and expensive. For instance, in the field of hepatology, elastography is increasingly being used to monitor liver fibrosis in patients with chronic hepatitis C, offering more precise, less painful assessments compared to liver biopsies. The growing recognition of elastography's potential to improve diagnostic accuracy, reduce patient discomfort, and lower healthcare costs is driving its adoption across hospitals, clinics, and diagnostic centers. As patients and clinicians become more aware of its advantages, elastography is gaining popularity as a first-line diagnostic tool, creating a substantial market opportunity for manufacturers and service providers. With its expanding acceptance, elastography is poised to play a pivotal role in the early detection and management of chronic diseases.

Restraints/Challenges

• High Cost of Elastography Systems

One of the major challenges facing the elastography imaging market is the high cost of elastography systems, which can limit their accessibility, particularly in low-resource settings. Advanced technologies such as high-resolution ultrasound and MRI-based elastography systems require significant capital investment, making them costly for many healthcare facilities, especially smaller hospitals or those in developing countries. The expense of purchasing, maintaining, and training staff to use these systems can be a barrier for facilities with limited budgets, resulting in slower adoption and reduced availability. This high cost also hinders the ability of smaller clinics and hospitals to incorporate elastography into their diagnostic services. As a result, while elastography offers valuable diagnostic capabilities, its cost remains a key challenge that can limit widespread adoption, especially in regions where affordable healthcare is a pressing need. Finding ways to reduce the cost of elastography systems or develop more affordable models could present an opportunity to expand its use and drive growth in the market.

• Regulatory and Reimbursement Issues

Regulatory and reimbursement issues represent a significant challenge for the elastography imaging market, as they can impede the widespread adoption of this advanced diagnostic technology. Obtaining regulatory approval for elastography systems can be a time-consuming and expensive process, particularly in regions such as the U.S. and Europe, where strict guidelines must be met before a new medical device can be marketed. For instance, in the U.S., elastography devices must undergo rigorous review by the FDA to ensure their safety and efficacy, which may delay their availability to healthcare providers and patients. In addition, reimbursement for elastography procedures is often limited or inconsistent across different healthcare systems. Many insurers may not fully cover the costs of elastography imaging, particularly in outpatient settings or for non-liver-related indications. This creates financial barriers for healthcare providers, especially smaller clinics or facilities in low-resource areas, making it difficult for them to justify the upfront costs of purchasing and maintaining elastography equipment. Without adequate reimbursement, healthcare providers may be reluctant to adopt elastography imaging, limiting its market penetration and accessibility for patients. As a result, regulatory and reimbursement challenges are key obstacles that hinder the growth of the elastography imaging market, reducing its potential to improve diagnostic outcomes in various medical fields.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Elastography Imaging Market Scope

The market is segmented on the basis of technique, modality, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Ultrasound Elastography Imaging
• 1D Transient Elastography
• Point Shear-Wave Elastography
• Shear-Wave Elastography
• Magnetic Resonance Elastography

Modality

• Portable
• On-Platform

Application

• Radiology/General Imaging
• Cardiology
• Obstetrics/Gynecology
• Urology
• Vascular
• Orthopedic and Musculoskeletal
• Others

End Users

• Hospitals
• Clinics
• Diagnostic Laboratories
• Surgical Centers and Diagnostic Centers
• Ambulatory Surgical Centers
• Others

Elastography Imaging Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, technique, modality, application, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the elastography imaging market, primarily driven by the presence of numerous key global players in the healthcare and medical device sectors. This region benefits from significant investments in research and development by manufacturers, who are focused on the commercialization and innovation of elastography systems. Moreover, the rising importance of these imaging technologies among healthcare professionals and end-users, particularly for diagnosing liver diseases and musculoskeletal conditions, contributes to this market growth. The increasing adoption of elastography imaging in clinical settings and the growing demand for non-invasive diagnostic procedures further solidify North America's leading position in this market.

Asia-Pacific is expected to witness significant growth in the elastography imaging market from 2025 to 2032, driven by an expanding geriatric population who are more susceptible to conditions that require diagnostic imaging, such as liver diseases and musculoskeletal disorders. The region's rapid economic development has led to improved healthcare infrastructure and increased investments in medical technologies, further facilitating market expansion. In addition, rising healthcare awareness and enhanced access to better medical services, particularly in emerging economies, are contributing to the growing demand for advanced diagnostic solutions. The combination of these factors positions Asia-Pacific as a key area for growth in the elastography imaging market during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Elastography Imaging Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Elastography Imaging Market Leaders Operating in the Market Are:

• General Electric Company (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• Canon U.S.A., Inc. (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Hitachi, Ltd. (Japan)
• SAMSUNG (South Korea)
• FUJIFILM Corporation (Japan)
• Esaote SPA (Italy)
• SuperSonic Imagine (France)
• Resoundant, Inc. (U.S.)
• Advanced Instrumentations (U.S.)
• Carestream Health (U.S.)
• Hologic Inc. (U.S.)
• GE HealthCare (U.S.)
• Medtronic (Ireland)
• Shimadzu Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• Shenzhen Landwind Industry Co., Ltd. (China)
• SonoScape Medical Corp (China)

Latest Developments in Elastography Imaging Market

• In November 2023, ZEISS unveiled a new Lattice Structured Illumination Microscopy (SIM) technology, aimed at overcoming the resolution limits of conventional light microscopy, enhancing imaging capabilities for high-resolution imaging applications
• In July 2023, at the Microscopy and Microanalysis (M&M) 2023 Conference, ZEISS Microscopy showcased its latest innovations and introduced interactive display features to highlight new research, offering a glimpse into the future of microscopy technology
• In June 2023, Nikon Instruments Inc. launched the “ECLIPSE Ui” system, a comprehensive microscope-based viewing platform designed for seamless clinical observations, supporting both in-person and remote pathological assessments
• In November 2022, PENTAX Medical introduced its new Performance Endoscopic Ultrasound (EUS) system in Canada, combining the ARIETTA 65 PX ultrasound scanner with the J10 Series Ultrasound Gastroscope, enhancing image quality, enabling real-time tissue elastography, and improving therapeutic access
• In May 2022, Mindray released its Resona I9 Advanced Technologies, incorporating HiFR Sound Touch Elastography, which offers smoother transition times, faster refresh rates, and improved consistency for 2D shear wave imaging
• In March 2022, Fujifilm Healthcare Europe launched the Arietta ultrasound series, including the Arietta 850 DeepInsight and Arietta 650 DeepInsight models, supporting the diagnosis of liver diseases such as hepatitis and cirrhosis by using Real-time Tissue Elastography (RTE) and Shear Wave Measurement (SWM) to color-code and quantify tissue stiffness

SKU-43616